Bristol Myers Squibb Co. (BMY)
67.31
+0.30
(+0.45%)
USD |
NYSE |
Aug 24, 16:00
67.13
-0.18
(-0.27%)
After-Hours: 20:00
Bristol Myers Squibb Price to Book Value : 6.161 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 6.134 |
| August 20, 2026 | 5.993 |
| August 19, 2026 | 6.189 |
| August 18, 2026 | 6.046 |
| August 17, 2026 | 5.916 |
| August 14, 2026 | 5.843 |
| August 13, 2026 | 5.918 |
| August 12, 2026 | 5.831 |
| August 11, 2026 | 5.823 |
| August 10, 2026 | 5.935 |
| August 07, 2026 | 5.924 |
| August 06, 2026 | 5.872 |
| August 05, 2026 | 5.824 |
| August 04, 2026 | 6.031 |
| August 03, 2026 | 5.993 |
| July 31, 2026 | 5.978 |
| July 30, 2026 | 5.937 |
| July 29, 2026 | 5.776 |
| July 28, 2026 | 5.822 |
| July 27, 2026 | 5.726 |
| July 24, 2026 | 5.684 |
| July 23, 2026 | 5.630 |
| July 22, 2026 | 5.562 |
| July 21, 2026 | 5.577 |
| July 20, 2026 | 5.507 |
| Date | Value |
|---|---|
| July 17, 2026 | 5.560 |
| July 16, 2026 | 5.539 |
| July 15, 2026 | 5.375 |
| July 14, 2026 | 5.213 |
| July 13, 2026 | 5.432 |
| July 10, 2026 | 5.271 |
| July 09, 2026 | 5.304 |
| July 08, 2026 | 5.267 |
| July 07, 2026 | 5.306 |
| July 06, 2026 | 5.190 |
| July 02, 2026 | 5.321 |
| July 01, 2026 | 5.166 |
| June 30, 2026 | 5.274 |
| June 29, 2026 | 5.959 |
| June 26, 2026 | 5.853 |
| June 25, 2026 | 5.636 |
| June 24, 2026 | 5.596 |
| June 23, 2026 | 5.650 |
| June 22, 2026 | 5.566 |
| June 18, 2026 | 5.495 |
| June 17, 2026 | 5.625 |
| June 16, 2026 | 5.690 |
| June 15, 2026 | 5.723 |
| June 12, 2026 | 5.813 |
| June 11, 2026 | 5.790 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.739 |
| Eli Lilly & Co. | 34.67 |
| Merck & Co., Inc. | 8.873 |
| Pfizer Inc. | 1.872 |
| AstraZeneca PLC | 10.93 |
Price to Book Value Related Metrics
| PE Ratio | 14.83 |
| PS Ratio | 2.796 |
| PEG Ratio | 0.1783 |
| Price to Free Cash Flow | 12.02 |
| Price | 67.31 |
| Earnings Yield | 6.74% |
| Market Cap | 137.51B |
| PEGY Ratio | 0.1707 |
| Operating PE Ratio | 8.643 |
| Normalized PE Ratio | 10.96 |